Abstract:Background Amyotrophic lateral sclerosis (ALS) is a disease that causes progressive degeneration of neurons present in the spinal cord and cerebral cortex. It is a disease with a progressive course, with worsening disability and death 3 to 5 years after diagnosis. However, some patients seem to have a slower progression, while others maintain a rapid progression, which may influence the clinical course of the disease and accelerate death. Objectives To evaluate the survival time of patients with ALS, according to the progression of the disease in rapid or slow, and to compare the level of functionality between two evaluations. Methods A longitudinal case series study that followed patients with a confirmed diagnosis of ALS from August 2018 to February 2022. Data were collected from medical records of periodic evaluations, in which pulmonary function tests were performed and the ALS Functional Assessment Scale (ALSFRS-r) was applied. From the values obtained in the scale, the progression rate was calculated, where the patients were divided into slow or rapid progression and followed for 3.5 years for statistical analysis of survival, later performed by the Kaplan-Meyer test. The results of the scores of the first and second evaluation of each patient were compared using the paired t-test. Results 11 patients were followed, 7 with rapid progression (63%) and 4 slow (37%) with a mean age of 61.64 years and forced vital capacity (FVC): 62.2 (38.7-85.7)%pred. In the functionality evaluation, it was observed that there was a significant reduction (p<0.01) in the total scale score compared to the first evaluation. The survival percentage was 0%, where all patients died at the end of the study, but the median survival of the slow progression group from the first evaluation until the final outcome was 46 months, while the rapid progression group was 28 months, with no significant difference between the survival curves (HR = 0.42; CI 0.12 - 1.48). Conclusion The present study was able to demonstrate that after the second evaluation ALS patients may have significant losses of functionality by the decline of the ALSFRS-r functional score. Also, it can determine the evolution of the disease and assist in identifying the speed of progression of the pathology. Implications Regular use of the ALS functional assessment scale and calculation of the rate of progression in the outpatient clinical setting becomes essential to chart a better short- and long-term prognosis and follow-up of the disease.

Clinical Determinants of Disease Progression in Amyotrophic Lateral Sclerosis—A Retrospective Cohort Study

Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United States

ANALYSIS OF SURVIVAL TIME AND FUNCTIONAL PROGRESSION IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: A LONGITUDINAL STUDY

Prognostic factors in ALS: A critical review

Assessing disease progression in ALS: prognostic subgroups and outliers

Analysis of survival in 106 patients with amyotrophic lateral sclerosis

Quantifying disease progression in amyotrophic lateral sclerosis

Profiles of disease progression and predictors of mortality in Colombian patients with amyotrophic lateral sclerosis: a comprehensive longitudinal study

A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials

Epidemiology and factors predicting survival of amyotrophic lateral sclerosis in a large Chinese cohort

Predictors of survival in patients with amyotrophic lateral sclerosis: A large meta-analysis

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis

The Predictors of Survival in Chinese Amyotrophic Lateral Sclerosis Patients.

Autonomic dysfunction is associated with disease progression and survival in amyotrophic lateral sclerosis: a prospective longitudinal cohort study

Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis

Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data

What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?

Spatial–temporal Pattern of Propagation in Amyotrophic Lateral Sclerosis and Effect on Survival: A Cohort Study

Prognosis of amyotrophic lateral sclerosis with cognitive and behavioural changes based on a sixty-month longitudinal follow-up

Predictors of survival in frontotemporal lobar degeneration syndromes

Clinical and genetic factors affecting diagnostic timeline of amyotrophic lateral sclerosis: a 15-year retrospective study